Total Artificial Heart – Medical Devices Pipeline Assessment, 2016


Posted December 8, 2016 by Shirley

“Total Artificial Heart – Medical Devices Pipeline Assessment, 2016″ provides an overview of Total Artificial Heart currently in pipeline stage.

 
MRRS adds "Total Artificial Heart – Medical Devices Pipeline Assessment, 2016" latest studies, published in Nov 2016.

Summary
GlobalData’s Medical Devices sector report, “Total Artificial Heart – Medical Devices Pipeline Assessment, 2016″ provides an overview of Total Artificial Heart currently in pipeline stage.

Scope
– Extensive coverage of the Total Artificial Heart under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Total Artificial Heart and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Total Artificial Heart Overview 6
3 Products under Development 7
3.1 Total Artificial Heart - Pipeline Products by Stage of Development 7
3.2 Total Artificial Heart - Pipeline Products by Territory 8
3.3 Total Artificial Heart - Pipeline Products by Regulatory Path 9
3.4 Total Artificial Heart - Pipeline Products by Estimated Approval Date 10
3.5 Total Artificial Heart - Ongoing Clinical Trials 11
4 Total Artificial Heart - Pipeline Products under Development by Companies 12
4.1 Total Artificial Heart Companies - Pipeline Products by Stage of Development 12
4.2 Total Artificial Heart - Pipeline Products by Stage of Development 13
5 Total Artificial Heart Companies and Product Overview 14
5.1 Abiomed, Inc. Company Overview 14
5.1.1 Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 BiVacor Pty Ltd Company Overview 16
5.2.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Carmat SAS Company Overview 17
5.3.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Cleveland Heart, Inc. Company Overview 21
5.4.1 Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Foster-Miller, Inc. (Inactive) Company Overview 23
5.5.1 Foster-Miller, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 MicroMed Cardiovascular, Inc. Company Overview 24
5.6.1 MicroMed Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 SynCardia Systems, Inc. Company Overview 25
5.7.1 SynCardia Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 The University of Tokyo Company Overview 34
5.8.1 The University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 34
6 Total Artificial Heart- Recent Developments 35...

List of Tables and Figures
Table 1: Total Artificial Heart - Pipeline Products by Stage of Development 7
Table 2: Total Artificial Heart - Pipeline Products by Territory 8
Table 3: Total Artificial Heart - Pipeline Products by Regulatory Path 9
Table 4: Total Artificial Heart - Pipeline Products by Estimated Approval Date 10
Table 5: Total Artificial Heart - Ongoing Clinical Trials 11
Table 6: Total Artificial Heart Companies - Pipeline Products by Stage of Development 12
Table 7: Total Artificial Heart - Pipeline Products by Stage of Development 13
Table 8: Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: AbioCor II - Product Status 15
Table 10: AbioCor II - Product Description 15
Table 11: BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
Table 12: BiVACOR Device - Product Status 16
Table 13: BiVACOR Device - Product Description 16
Table 14: Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 17
Table 15: Artificial Heart - Product Status 18
Table 16: Artificial Heart - Product Description 18
Table 17: Carmat SAS - Ongoing Clinical Trials Overview 19
Table 18: Artificial Heart - First-in-man CARMAT’s Bioprosthetic Heart Trial For End-stage Heart Failure 20
Table 19: Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 20: SmartHeart TAH - Product Status 22
Table 21: SmartHeart TAH - Product Description 22
Table 22: Foster-Miller, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
Table 23: MagScrew Total Artificial Heart - Product Status 23
Table 24: MagScrew Total Artificial Heart - Product Description 23 ...

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/total-artificial-heart-medical-devices-pipeline-assessment-2016

Ask a sample or any futher questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Medical , Research
Last Updated December 8, 2016